MARSHALL WACE, LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$765,000
-50.6%
41,904
-50.8%
0.00%
-50.0%
Q4 2020$1,549,000
-19.6%
85,088
-21.2%
0.01%
-33.3%
Q3 2020$1,927,000
-48.0%
108,028
-47.7%
0.01%
-53.8%
Q2 2020$3,707,000
+186.9%
206,752
+143.0%
0.03%
+100.0%
Q1 2020$1,292,000
-65.9%
85,088
-55.7%
0.01%
-50.0%
Q4 2019$3,786,000
-89.3%
191,879
-90.7%
0.03%
-90.7%
Q3 2019$35,428,000
-3.7%
2,059,728
-0.9%
0.28%
-7.9%
Q2 2019$36,799,000
-69.5%
2,079,070
-64.9%
0.30%
-46.8%
Q1 2019$120,762,0005,928,4140.57%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders